share_log

Neumora Therapeutics(NMRA.US) 10% Shareholder Buys US$412.14K in Common Stocks

moomoo News ·  11/16/2023 08:32

$Neumora Therapeutics (NMRA.US)$ 10% Shareholder ARCH Venture Partners XII, LLC purchased 35,010 shares of Common Stocks on Nov 13, 14, 2023 at an average price of $11.77 for a total value of $412.14K.

This transaction involves other related parties: ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, GILLIS STEVEN, NELSEN ROBERT and Burow Kristina.

1700094764450575006.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment